HealthDay on MSN18h
Risk for Chronic Fatigue Syndrome Higher After COVID-19
The risk for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is increased following COVID-19, according to study findings.
News Medical on MSN23h
Tofacitinib reduces SARS-CoV-2 infection risk in patients with PTPN2 deficiency
Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in ...
News Medical on MSN1d
COVID-19 dramatically raises the risk of developing ME/CFS
Study highlights a fourfold increase in ME/CFS risk among COVID-19 patients, with 89% of post-COVID ME/CFS cases overlapping ...
Pharmabiz1d
InflaRx receives European marketing authorization for Gohibicto treat of SARS-CoV-2-induced acute respiratory distress syndrome
InflaRx receives European marketing authorization for Gohibicto treat of SARS-CoV-2-induced acute respiratory distress syndrome: Jena, Germany Friday, January 17, 2025, 11:00 Hrs ...